• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奥沙利铂的生物转化和药代动力学的新见解。

New insights into the biotransformation and pharmacokinetics of oxaliplatin.

机构信息

Karolinska Pharmacy, Karolinska University Hospital, SE-171 76 Stockholm, Sweden.

出版信息

J Pharm Sci. 2009 Nov;98(11):3879-85. doi: 10.1002/jps.21732.

DOI:10.1002/jps.21732
PMID:19340883
Abstract

Oxaliplatin is used primarily in the treatment of metastatic colorectal cancer. In this minireview, we discuss potentially important biotransformation pathways in light of its short elimination half-life in vivo. We also highlight new information achieved using a selective analytical technique to measure intact oxaliplatin in pharmacokinetic studies (comprising intravenous, intraperitoneal, and intrahepatic administration) and compare to results obtained by measurements of total platinum. The use of selective analytical techniques is strongly recommended giving kinetic parameters of the parent compound and not only to a complex mixture of platinum containing endogenous compounds.

摘要

奥沙利铂主要用于转移性结直肠癌的治疗。在这篇简评中,我们根据其在体内较短的消除半衰期,讨论了一些潜在重要的生物转化途径。我们还使用选择性分析技术来测量药代动力学研究中(包括静脉、腹腔和肝内给药)完整奥沙利铂的新信息,并且与总铂测量结果进行比较。强烈建议使用选择性分析技术,因为这样可以获得母体化合物的动力学参数,而不仅仅是包含内源性化合物的复杂铂混合物的参数。

相似文献

1
New insights into the biotransformation and pharmacokinetics of oxaliplatin.奥沙利铂的生物转化和药代动力学的新见解。
J Pharm Sci. 2009 Nov;98(11):3879-85. doi: 10.1002/jps.21732.
2
Clinical pharmacokinetics of oxaliplatin: a critical review.奥沙利铂的临床药代动力学:一项批判性综述。
Clin Cancer Res. 2000 Apr;6(4):1205-18.
3
Oxaliplatin biotransformation and pharmacokinetics: a pilot study to determine the possible relationship to neurotoxicity.奥沙利铂的生物转化及药代动力学:一项旨在确定其与神经毒性可能关系的初步研究。
Anticancer Res. 2002 Jul-Aug;22(4):2301-9.
4
Oxaliplatin: pharmacokinetics and chronopharmacological aspects.奥沙利铂:药代动力学与时辰药理学方面
Clin Pharmacokinet. 2000 Jan;38(1):1-21. doi: 10.2165/00003088-200038010-00001.
5
Pharmacokinetics and biotransformations of oxaliplatin in comparison with ormaplatin following a single bolus intravenous injection in rats.大鼠单次静脉推注后奥沙利铂与奥马铂的药代动力学及生物转化比较
Cancer Chemother Pharmacol. 1999;44(1):19-28. doi: 10.1007/s002800050940.
6
Pharmacokinetics of oxaliplatin in patients with severe hepatic dysfunction.奥沙利铂在严重肝功能不全患者中的药代动力学。
Cancer Chemother Pharmacol. 2008 Jan;61(1):97-104. doi: 10.1007/s00280-007-0452-5. Epub 2007 Mar 30.
7
Cumulative pharmacokinetic study of oxaliplatin, administered every three weeks, combined with 5-fluorouracil in colorectal cancer patients.每三周给药一次的奥沙利铂联合5-氟尿嘧啶用于结直肠癌患者的累积药代动力学研究。
Clin Cancer Res. 1997 Jun;3(6):891-9.
8
Pharmacokinetics of oxaliplatin in humans.奥沙利铂在人体内的药代动力学。
Med Oncol. 2002;19(4):261-5. doi: 10.1385/MO:19:4:261.
9
Interindividual differences in oxaliplatin pharmacokinetics.奥沙利铂药代动力学的个体间差异。
Int J Clin Pharmacol Ther. 2002 Dec;40(12):569-70. doi: 10.5414/cpp40569.
10
Oxaliplatin in patients with metastatic colorectal cancer: efficacy and pharmacokinetics parameters.奥沙利铂用于转移性结直肠癌患者:疗效及药代动力学参数
J BUON. 2010 Apr-Jun;15(2):263-9.

引用本文的文献

1
Modulating Hyperpolarization-Activated Cation Currents through Small Molecule Perturbations: Magnitude and Gating Control.通过小分子扰动调节超极化激活阳离子电流:幅度与门控控制
Biomedicines. 2023 Aug 2;11(8):2177. doi: 10.3390/biomedicines11082177.
2
Pharmacologic Effects of Oxaliplatin Instability in Chloride-Containing Carrier Fluids on the Hyperthermic Intraperitoneal Chemotherapy to Treat Colorectal Cancer In Vitro and In Vivo.含氯载体液中奥沙利铂不稳定性对体外和体内治疗结直肠癌的腹腔热化疗的药理作用。
Ann Surg Oncol. 2022 Dec;29(13):8583-8592. doi: 10.1245/s10434-022-12358-7. Epub 2022 Aug 30.
3
Designing a Mucoadhesive ChemoPatch to Ablate Oral Dysplasia for Cancer Prevention.
设计一种用于预防癌症的黏附性化疗贴片以消融口腔发育异常。
Small. 2022 Jun;18(25):e2201561. doi: 10.1002/smll.202201561. Epub 2022 May 19.
4
Determination of Oxaliplatin by a UHPLC-MS/MS Method: Application to Pharmacokinetics and Tongue Tissue Distribution Studies in Rats.超高效液相色谱-串联质谱法测定奥沙利铂:在大鼠药代动力学及舌组织分布研究中的应用
Pharmaceuticals (Basel). 2021 Dec 31;15(1):52. doi: 10.3390/ph15010052.
5
The hybrid models, containing hydrolytic and electron-driven processes, in theoretical study of oxaliplatin biotransformation.在奥沙利铂生物转化的理论研究中,包含水解和电子驱动过程的混合模型。
J Mol Model. 2020 Sep 26;26(10):286. doi: 10.1007/s00894-020-04549-4.
6
Characterization in Dual Activation by Oxaliplatin, a Platinum-Based Chemotherapeutic Agent of Hyperpolarization-Activated Cation and Electroporation-Induced Currents.奥沙利铂的双重激活作用的特性:一种基于铂的化疗药物,可使超极化激活阳离子和电穿孔诱导电流增强。
Int J Mol Sci. 2020 Jan 8;21(2):396. doi: 10.3390/ijms21020396.
7
Hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal carcinomatosis: a clinical pharmacological perspective on a surgical procedure.腹腔内热灌注化疗联合奥沙利铂治疗腹膜转移癌:手术治疗的临床药理学视角。
Br J Clin Pharmacol. 2019 Jan;85(1):47-58. doi: 10.1111/bcp.13773. Epub 2018 Oct 25.
8
Pharmacologic Properties of the Carrier Solutions for Hyperthermic Intraperitoneal Chemotherapy: Comparative Analyses Between Water and Lipid Carrier Solutions in the Rat Model.高热腹腔化疗载体溶液的药理学特性:水载体溶液和脂质载体溶液在大鼠模型中的比较分析。
Ann Surg Oncol. 2018 Oct;25(11):3185-3192. doi: 10.1245/s10434-018-6628-x. Epub 2018 Jul 18.
9
Predicting effects on oxaliplatin clearance: in vitro, kinetic and clinical studies of calcium- and magnesium-mediated oxaliplatin degradation.预测奥沙利铂清除率的影响:钙镁介导奥沙利铂降解的体外、动力学和临床研究。
Sci Rep. 2017 Jun 22;7(1):4073. doi: 10.1038/s41598-017-04383-4.
10
Chemical Imaging of Platinum-Based Drugs and their Metabolites.铂类药物及其代谢物的化学成像。
Sci Rep. 2016 Dec 5;6:38507. doi: 10.1038/srep38507.